Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice

Petteri Rinne1, James J Kadiri2, Mauricio Velasco-Delgado2

  • 1From the Institute of Biomedicine, Research Center for Integrative Physiology and Pharmacology, Turku Center for Disease Modeling, University of Turku, Finland (P.R., J.J.K., M.V.-D., S.N., E.S.); Medicity Research Laboratory Turku, University of Turku, Finland (M.V., M.H.); Unit of Clinical Pharmacology, Turku University Hospital, Finland (E.S.); Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU), Munich, Germany (P.R., M.R., S.S.); and German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Germany (S.S.). pperin@utu.fi.

Abstract

Insights

Melanocortin 1 receptor (MC1-R) deficiency worsens atherosclerosis by impairing cholesterol regulation and increasing monocyte accumulation in arteries. This dysfunction leads to larger, more vulnerable lesions and disrupted lipid metabolism.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Metabolic Disease

Background:

  • Melanocortin 1 receptor (MC1-R) mediates anti-inflammatory actions in monocytes and macrophages.
  • MC1-R promotes cholesterol efflux via ABCA1 and ABCG1, protecting against macrophage foam cell formation.

Purpose of the Study:

  • To investigate the impact of global MC1-R deficiency on atherosclerosis development.
  • To determine if MC1-R signaling influences cholesterol handling and inflammatory cell recruitment in atherosclerosis.

Main Methods:

  • Apolipoprotein E-deficient mice were crossed with MC1-R dysfunctional mice (Mc1re/e) and fed a high-fat diet.
  • Atherosclerotic lesion development, plaque composition, gene expression, bile acid metabolism, and leukocyte profiles were analyzed.

Main Results:

  • MC1-R deficiency led to significantly larger atherosclerotic lesions with increased necrotic cores and reduced collagen.
  • Reduced ABCA1 and ABCG1 expression, impaired bile acid metabolism, and aggravated hypercholesterolemia were observed.
  • Dysfunctional MC1-R enhanced arterial accumulation of Ly6Chigh monocytes and macrophages, with increased expression of adhesion molecules.

Conclusions:

  • MC1-R plays a crucial role in regulating atherosclerosis development.
  • MC1-R deficiency exacerbates atherosclerosis by disrupting cholesterol homeostasis and increasing arterial monocyte infiltration.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
453
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.2K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
652